Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2002 4
2003 7
2004 8
2005 5
2006 6
2007 6
2008 7
2009 9
2010 11
2011 14
2012 11
2013 13
2014 11
2015 14
2016 7
2017 15
2018 14
2019 25
2020 7
2021 5
2022 11
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

195 results

Results by year

Filters applied: . Clear all
Page 1
Exploring barriers and enablers of antibiotic amnesty campaigns.
Howard P, Hawksworth G, Hussain S, Khan N, Bahadar R, Msindo J, Frank S, Aldeyab MA. Howard P, et al. J Pharm Policy Pract. 2024 Feb 29;17(1):2316033. doi: 10.1080/20523211.2024.2316033. eCollection 2024. J Pharm Policy Pract. 2024. PMID: 38434723 Free PMC article.
Developing a model for decision-making around antibiotic prescribing for patients with COVID-19 pneumonia in acute NHS hospitals during the first wave of the COVID-19 pandemic: qualitative results from the Procalcitonin Evaluation of Antibiotic use in COVID-19 Hospitalised patients (PEACH Study).
Henley J, Brookes-Howell L, Euden J, Pallmann P, Llewelyn M, Howard P, Powell N, Dark P, Szakmany T, Hellyer TP, Albur M, Hamilton R, Prestwich G, Ogden M, Maboshe W, Sandoe J, Thomas-Jones E, Carrol E; PEACH study group (Procalcitonin Evaluation of Antibiotic use in COVID-19 Hospitalised patients); PEACH consortium (Procalcitonin Evaluation of Antibiotic use in COVID-19 Hospitalised patients). Henley J, et al. Among authors: howard p. BMJ Open. 2023 Dec 19;13(12):e077117. doi: 10.1136/bmjopen-2023-077117. BMJ Open. 2023. PMID: 38114276 Free PMC article.
Penicillin allergy status and its effect on antibiotic prescribing, patient outcomes and antimicrobial resistance (ALABAMA): protocol for a multicentre, parallel-arm, open-label, randomised pragmatic trial.
Armitage KF, Porter CE, Ahmed S, Cook J, Boards J, Bongard E, Butler CC, Corfield K, Davoudianfar M, Galal U, Howard P, Mujica-Mota R, Saman R, Santillo M, Savic S, Shinkins B, Tonkin-Crine S, Wanat M, West RM, Yu LM, Pavitt S, Sandoe JAT. Armitage KF, et al. Among authors: howard p. BMJ Open. 2023 Sep 4;13(9):e072253. doi: 10.1136/bmjopen-2023-072253. BMJ Open. 2023. PMID: 37666558 Free PMC article.
Comparison of Pyrrolobenzodiazepine Dimer Bis-imine versus Mono-imine: DNA Interstrand Cross-linking, Cytotoxicity, Antibody-Drug Conjugate Efficacy and Toxicity.
Tiberghien AC, Vijayakrishnan B, Esfandiari A, Ahmed M, Pardo R, Bingham J, Adams L, Santos K, Kang GD, Pugh KM, Afif-Rider S, Vashisht K, Haque K, Tammali R, Rosfjord E, Savoca A, Hartley JA, Howard PW. Tiberghien AC, et al. Among authors: howard pw. Mol Cancer Ther. 2023 Feb 1;22(2):254-263. doi: 10.1158/1535-7163.MCT-21-0693. Mol Cancer Ther. 2023. PMID: 36722141
195 results